Silverfin false false 31/01/2026 01/02/2025 31/01/2026 I Seragnoli 31/01/2022 31 July 2026 no description of principal activity 13881660 2026-01-31 13881660 bus:Director1 2026-01-31 13881660 2025-01-31 13881660 core:CurrentFinancialInstruments 2026-01-31 13881660 core:CurrentFinancialInstruments 2025-01-31 13881660 core:RetainedEarningsAccumulatedLosses 2026-01-31 13881660 core:RetainedEarningsAccumulatedLosses 2025-01-31 13881660 core:CostValuation 2025-01-31 13881660 core:CostValuation 2026-01-31 13881660 core:AdditionsToInvestments 2026-01-31 13881660 core:DisposalsRepaymentsInvestments 2026-01-31 13881660 core:RevaluationsIncreaseDecreaseInInvestments 2026-01-31 13881660 2025-02-01 2026-01-31 13881660 bus:FilletedAccounts 2025-02-01 2026-01-31 13881660 bus:SmallEntities 2025-02-01 2026-01-31 13881660 bus:AuditExemptWithAccountantsReport 2025-02-01 2026-01-31 13881660 bus:CompanyLimitedByGuarantee 2025-02-01 2026-01-31 13881660 bus:Director1 2025-02-01 2026-01-31 13881660 2024-02-01 2025-01-31 iso4217:GBP xbrli:pure

Company No: 13881660 (England and Wales)

CLG LEGACY LIMITED

(A company limited by guarantee)

Unaudited Financial Statements
For the financial year ended 31 January 2026
Pages for filing with the registrar

CLG LEGACY LIMITED

Unaudited Financial Statements

For the financial year ended 31 January 2026

Contents

CLG LEGACY LIMITED

COMPANY INFORMATION

For the financial year ended 31 January 2026
CLG LEGACY LIMITED

COMPANY INFORMATION (continued)

For the financial year ended 31 January 2026
DIRECTOR I Seragnoli
REGISTERED OFFICE C/O S&W Partners Llp Onslow House
Onslow Street
Guildford
GU1 4TL
United Kingdom
COMPANY NUMBER 13881660 (England and Wales)
ACCOUNTANT S&W Partners LLP
103 Colmore Row
Birmingham
B3 3AG
CLG LEGACY LIMITED

BALANCE SHEET

As at 31 January 2026
CLG LEGACY LIMITED

BALANCE SHEET (continued)

As at 31 January 2026
Note 2026 2025
£ £
Fixed assets
Investments 3 1,195,986 1,164,112
1,195,986 1,164,112
Current assets
Cash at bank and in hand 13,440 16,498
13,440 16,498
Creditors: amounts falling due within one year 4 ( 1,178,905) ( 1,173,045)
Net current liabilities (1,165,465) (1,156,547)
Total assets less current liabilities 30,521 7,565
Net assets 30,521 7,565
Reserves
Profit and loss account 30,521 7,565
Total reserves 30,521 7,565

For the financial year ending 31 January 2026 the Company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Director's responsibilities:

The financial statements of CLG Legacy Limited (registered number: 13881660) were approved and authorised for issue by the Director on 31 July 2026. They were signed on its behalf by:

I Seragnoli
Director
CLG LEGACY LIMITED

NOTES TO THE FINANCIAL STATEMENTS

For the financial year ended 31 January 2026
CLG LEGACY LIMITED

NOTES TO THE FINANCIAL STATEMENTS

For the financial year ended 31 January 2026
1. Accounting policies

The principal accounting policies are summarised below. They have all been applied consistently throughout the financial year and to the preceding financial year, unless otherwise stated.

General information and basis of accounting

CLG Legacy Limited (the Company) is a private company, limited by guarantee, incorporated in the United Kingdom under the Companies Act 2006 and is registered in England and Wales. The address of the Company's registered office is C/O S&W Partners Llp Onslow House, Onslow Street, Guildford, GU1 4TL, United Kingdom.

The financial statements have been prepared under the historical cost convention, modified to include certain items at fair value, and in accordance with ‘The Financial Reporting Standard applicable in the UK and the Republic of Ireland’ issued by the Financial Reporting Council, including Section 1A of Financial Reporting Standard 102 (FRS102), and the requirements of the Companies Act 2006 as applicable to companies subject to the small companies regime.

The functional currency of CLG Legacy Limited is considered to be pounds sterling because that is the currency of the primary economic environment in which the Company operates.

These financial statements are separate financial statements.

Going concern

The financial statements have been prepared on a going concern basis.

The director has made an assessment in preparing these financial statements as to whether the Company is a going concern and have concluded that there are no material uncertainties that may cast significant doubt on the Company's ability to continue as a going concern for a period of at least 12 months from the date of approval of these financial statements.

Foreign currency

Transactions in foreign currencies are recorded at the rate of exchange at the date of the transaction. Monetary assets and liabilities denominated in foreign currencies at the Balance Sheet date are reported at the rates of exchange prevailing at that date.

Exchange differences are recognised in the Statement of Income and Retained Earnings in the period in which they arise on monetary items.

Interest income

Interest income is recognised when it is probable that the economic benefits will flow to the Company and the amount of revenue can be measured reliably. Interest income is accrued on a time basis, by reference to the principal outstanding at the effective interest rate applicable, which is the rate that exactly discounts estimated future cash receipts through the expected life of the financial asset to that asset's net carrying amount on initial recognition.

Taxation

Current tax
Current tax is provided at amounts expected to be paid (or recoverable) using the tax rates and laws that have been enacted or substantively enacted at the Balance Sheet date.

Impairment of assets

Assets, other than those measured at fair value, are assessed for indicators of impairment at each Balance Sheet date. If there is objective evidence of impairment, an impairment loss is recognised in the Statement of Income and Retained Earnings as described below.

Financial instruments

Financial assets and financial liabilities are recognised when the Company becomes a party to the contractual provisions of the instrument.

Investments in listed company shares are remeasured to market value at each balance sheet date. Gains and losses on remeasurement are recognised in profit or loss for the period.
Investments in unlisted company shares, whose market value can be reliably determined, are remeasured to market value at each balance sheet date. Gains and losses on remeasurement are recognised in profit or loss for the period. Where market value cannot be reliably determined, such investments are stated at historic cost less impairment.

Trade and other debtors and creditors are classified as basic financial instruments and measured on initial recognition at transaction price. Debtors and creditors are subsequently measured at amortised cost using the effective interest rate method. A provision is established when there is objective evidence that the Company will not be able to collect all amounts due.

Cash and cash equivalents are classified as basic financial instruments and comprise cash in hand and at bank, short term bank deposits with an original maturity of three months or less and bank overdrafts which are an integral part of the Company’s cash management.

Financial liabilities and equity instruments issued by the Company are classified in accordance with the substance of the contractual arrangements entered into and the definitions of a financial liability and an equity instrument. An equity instrument is any contract that evidences a residual interest in the assets of the Company after deducting all of
its liabilities. Equity instruments issued by the Company are recorded at the proceeds received, net of direct issue costs.

2. Employees

2026 2025
Number Number
Monthly average number of persons employed by the Company during the year, including the director 1 1

3. Fixed asset investments

Investments in subsidiaries

2026
£
Cost
At 01 February 2025 142,000
At 31 January 2026 142,000
Carrying value at 31 January 2026 142,000
Carrying value at 31 January 2025 142,000

On 2 May 2024, the Company acquired 100% of the issued quota capital of IST S.r.l., a private limited liability company incorporated and registered in Italy, for a total cash consideration of £142,000. IST S.r.l. is based in Milan, Italy.
The acquisition was settled entirely in cash, and no contingent consideration was agreed as part of the transaction.
The investment has been recognised in the Company's financial statements at cost, in accordance with the applicable accounting standards for individual financial statements.
The purchase consideration of £142,000 reflected the net assets (equity) of IST S.r.l. at the acquisition date. Accordingly, no acquisition premium arose on the transaction and, therefore, no amount would be attributable to goodwill or other acquisition-related intangible assets as a result of the acquisition.

Listed investments Total
£ £
Cost or valuation before impairment
At 01 February 2025 1,022,112 1,022,112
Additions 121,714 121,714
Disposals ( 92,536) ( 92,536)
Movement in fair value 2,696 2,696
At 31 January 2026 1,053,986 1,053,986
Carrying value at 31 January 2026 1,053,986 1,053,986
Carrying value at 31 January 2025 1,022,112 1,022,112

4. Creditors: amounts falling due within one year

2026 2025
£ £
Amounts owed to director 1,159,977 1,159,978
Accruals 10,537 10,036
Taxation and social security 8,391 3,031
1,178,905 1,173,045

5. Liability of members

The members of the CLG Legacy Limited have undertaken to contribute a sum not exceeding £1 each to meet the liabilities of the Company if it should be wound up.

6. Related party transactions

At the year end, there is an amount of £1,159,978 (2025 - £1,159,978) owed to the directors by the Company. These loans are unsecured, interest free and repayable on demand